C Oliver Hanemann
University of Plymouth
H-index: 56
Europe-United Kingdom
Top articles of C Oliver Hanemann
Meningioma: International Consortium on Meningiomas (ICOM) consensus review on scientific advances & treatment paradigms for clinicians, researchers, and patients
2024/5/2
Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
2024/4/10
Ammar Al-Chalabi
H-Index: 65
Kevin Talbot
H-Index: 59
C Oliver Hanemann
H-Index: 32
Antonio Scalfari
H-Index: 13
Alan Tennant
H-Index: 46
Adult brain tumour research in 2024: Status, challenges and recommendations
2024/4
Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials
2024/2
C Oliver Hanemann
H-Index: 32
Chetan Bettegowda
H-Index: 39
Ribogenesis boosts controlled by HEATR1-MYC interplay promote transition into brain tumour growth
EMBO reports
2024/1/12
Oliver Warrington
H-Index: 1
C Oliver Hanemann
H-Index: 32
A novel patient-derived meningioma spheroid model as a tool to study and treat epithelial-to-mesenchymal transition (EMT) in meningiomas
Acta Neuropathologica Communications
2023/12/15
Hypoxia-Induced FNDC3B Promotes EGR1/FSTL1 Mediated Angiogenesis in Glioma
2023/12/11
Preclinical Models of Meningioma
2023/7/12
C Oliver Hanemann
H-Index: 32
Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma
Brain
2023/4/3
Philip Edwards
H-Index: 18
C Oliver Hanemann
H-Index: 32
EXTH-90. HDAC INHIBITOR, CAY10603, IS A POTENT RADIOSENSITIZER IN MENINGIOMAS
Neuro-Oncology
2022/11
Clinical trials in pediatric ALS: a TRICALS feasibility study
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
2022/10/2
P18. 04. A Cay10603, HDAC6 inhibitor, enhances radiosensitivity in meningioma via supressing the nuclear beta-catenin accumulation
Neuro-Oncology
2022/9
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
Genetics in Medicine
2022/9/1
The four self-efficacy trajectories among people with multiple sclerosis: clinical associations and implications
Journal of the Neurological Sciences
2022/5/15
Dawn Langdon
H-Index: 32
C Oliver Hanemann
H-Index: 32
Helen Ford
H-Index: 7
Cathy Ellis
H-Index: 1
Alan Tennant
H-Index: 46
Proteomic analysis of genetically stratified meningioma
Brain Tumor Research and Treatment
2022/3/15
Human endogenous retrovirus type K promotes proliferation and confers sensitivity to antiretroviral drugs in merlin-negative schwannoma and meningioma
Cancer Research
2022/1/15
C Oliver Hanemann
H-Index: 32
Genotype-phenotype correlations in neurofibromatosis and their potential clinical use
Neurology
2021/8/17
REiNS: Genotype-Phenotype correlations in neurofibromatosis and their potential clinical use
2021/8/17
TAM receptors as potential therapeutic targets in NF2-related schwannomas and meningiomas
Cancer Research
2021/7/1
C Oliver Hanemann
H-Index: 32
Integrated phospho-proteogenomic and single-cell transcriptomic analysis of meningiomas establishes robust subtyping and reveals subtype-specific immune invasion
BioRxiv
2021/5/11
